In connection with entry into the Purchase Agreement and the associated reduction in force, on July 29, 2020, Lexicon Pharmaceuticals, Inc. determined to terminate the employment of Pablo Lapuerta, M.D., Executive Vice President and Chief Medical Officer, and Alexander A. Santini, Executive Vice President and Chief Commercial Officer, in each case effective as of September 30, 2020.